New antibodies target “dark side” of influenza virus protein
New antibodies have been developed to target a specific region of the influenza virus protein that is often overlooked. This region, known as the "dark side," is crucial for the…
Come to MedCity INVEST, Where You Could Meet Your Startup’s First Institutional Investor or a Future Portfolio Company!
MedCity News is hosting the MedCity INVEST 2024 conference in Chicago on May 21-22, bringing together healthcare investors, startups, and executives for networking and panel discussions on healthcare investment trends.…
Botox investigation reflects ‘growing trend’ of illegal supply of treatments
The Health Products Regulatory Authority in Ireland has warned about the growing trend of individuals providing prescription cosmetic treatments without a prescription. A recent RTE documentary showed non-medically licensed beauty…
Travelers’ Diarrhea Common Among Adults During Short-Term International Trips
Between 20% and 56% of international travelers from high-income countries are at risk for travelers' diarrhea during trips to tropical or subtropical destinations lasting less than 100 days. Pre-travel medical…
FarmboxRx launches Maternal Health Program for underserved populations
Tech-enabled food delivery company FarmboxRx is launching a Maternal Health Program to provide access to food and nutrition education for at-risk pregnant women. The program will focus on promoting health…
Why Hospitals in Many States With Legal Abortion May Refuse To Perform Them
Several states, including California, Michigan, and Pennsylvania, have laws protecting hospitals that refuse to provide reproductive healthcare. These laws shield providers, often Catholic hospitals, from liability for not offering services…
‘Early aggressive hydration’ essential to avoid complications in acute pancreatitis
The initial management for acute pancreatitis should include moderately aggressive fluid resuscitation and close monitoring of vital signs and urine output. A new guideline from the ACG emphasizes that early…
The latest on Novo Nordisk, Alnylam, Apogee
The biotech industry is constantly evolving with new developments in medications and treatments. Novo Nordisk's Ozempic has shown benefits beyond diabetes, while Alnylam Pharmaceuticals' zilebesiran has shown promise in lowering…
Medical apprenticeships: what we know so far, and what happens next
Two amendments have been made to Éabha Lynn's article (BMJ 2024;384:p2939, doi:10.1136/bmj.p2939) at the request of NHS England and the General Medical Council. Firstly, a sentence regarding GMC accreditation of…
Shady bleaching jabs fuel health fears, scams in W. Africa
Skin-whitening practices are popular in Africa and Asia due to the association of fair skin with status and beauty. Despite the risks and scams involved, the market for whitening treatments…